Mat Nor, M. N., Rupenthal, I. D., Green, C. R., & Acosta, M. L. (2019). Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease. Neurotherapeutics.
Chicago Stili AlıntıMat Nor, Mohd Nasir, Ilva D. Rupenthal, Colin R. Green, ve Monica L. Acosta. "Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease." Neurotherapeutics 2019.
MLA AlıntıMat Nor, Mohd Nasir, Ilva D. Rupenthal, Colin R. Green, ve Monica L. Acosta. "Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease." Neurotherapeutics 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..